IP Verse

Antitumoral Combination Comprising Cabazitaxel And Cisplatin - EP2678011

PATENT ANALYSIS

Patent Details

Grant Date
Jun 26, 2019
Company
AVENTIS PHARMA S.A.
Oppositions

GENERICS (U.K.) LIMITED

More patents of Aventis Pharma S.A.

EP2493466

EP3294285

EP2678011

Want to monitor this patent?

Feel free to send us a message here and we will get back to you